SCHEMBL5510320

SCHEMBL5510320

CC(C)(C)c1ccc(B(O)OC(C)(C)C(C)(C)O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 4/20 0.40
LMNA P02545 1/20 0.39
TYR P14679 1/20 0.39
TSHR P16473 1/20 0.35
CA1 P00915 1/20 0.34
CA2 P00918 1/20 0.34
CA9 Q16790 1/20 0.34
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
NPY4R P50391 1/20 0.33
NPY5R Q15761 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
MAPT P10636 3/20 0.32
ALDH1A1 P00352 2/20 0.32
HPGD P15428 2/20 0.32
NPC1 O15118 1/20 0.32
MAPK1 P28482 1/20 0.32
RAB9A P51151 1/20 0.32
HDAC1 Q13547 1/20 0.32
SLC22A2 O15244 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19433226 0.85 CA2 (0.42) TRPV1TSHRCA1CA2MGLL
SCHEMBL15751111 0.84 KIF11 (0.36) TRPV1LMNATYRALDH1A1HPGD
SCHEMBL3681691 0.83 CA2 (0.45) TSHRCA1CA2ALDH1A1TDP1
SCHEMBL1181137 0.83 ENPP2 (0.41) LMNATYRTSHRCA1CA2
SCHEMBL54815 0.81 MAPK1 (0.32) MAPTALDH1A1HPGDNPC1MAPK1
SCHEMBL117688 0.81 ENPP2 (0.43) TSHRMAPTMAPK1HIF1AORAI1
SCHEMBL9903022 0.81
SCHEMBL3711217 0.81
SCHEMBL119711 0.81 TRPV6 (0.39) CA1CA2ALDH1A1MAPK1HIF1A
SCHEMBL366006 0.80 CA1 (0.52) CA1CA2CA9MAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118561818-A Diaryl substituted 2, 3-indoline compound or medicinal salt thereof, preparation method and application thereof 河南大学 2024-08-30 CN claimed
CN-118561818-A Diaryl substituted 2, 3-indoline compound or medicinal salt thereof, preparation method and application thereof 河南大学 2024-08-30 CN disclosed
CN-115160348-B Method for directly borating aromatic C-H bond without metal catalysis under illumination 中山大学 2024-06-21 CN disclosed
US-20220098137-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME NEVADA RESEARCH & INNOVATION CORPORATION (US) 2022-03-31 US disclosed
US-11174211-B2 Aryl compounds and polymers and methods of making and using the same NEVADA RESEARCH & INNOVATION CORPORATION (US) 2021-11-16 US disclosed
EP-3271346-B1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME UNIV NEVADA RENO (US) 2021-05-05 EP disclosed
US-20200331831-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) 2020-10-22 US disclosed
US-10550056-B2 Aryl compounds and polymers and methods of making and using the same BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2020-02-04 US disclosed
US-20180244596-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA (US) 2018-08-30 US disclosed
EP-3271346-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno (US) 2018-01-24 EP disclosed
WO-2016149633-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) 2016-09-22 WO disclosed
US-20070040164-A1 Polymer complex compound and polymer light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200331831-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME AHR, TYR, PAH TRPV1 2289/4885LMNA 856/4885TYR 2/4885
US-20220098137-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME AHR, TYR, PAH TRPV1 2289/4885LMNA 856/4885TYR 2/4885
US-20180244596-A1 ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME AHR, TYR, PAH TRPV1 2289/4885LMNA 856/4885TYR 2/4885
US-11174211-B2 Aryl compounds and polymers and methods of making and using the same AHR, TYR, PAH TRPV1 2289/4885LMNA 856/4885TYR 2/4885
US-10550056-B2 Aryl compounds and polymers and methods of making and using the same AHR, TYR, PAH TRPV1 2289/4885LMNA 856/4885TYR 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.